March 2013 Scientist to Watch Emily Scott explains her work on a lung enzyme that interacts with nicotine and may serve as a drug target.
By Dan Cossins | March 1, 2013
Read the full story.
Sign In with your LabX Media Group Passport to leave a comment
Not a member? Register Now!
March 14, 2013
Any drug they will develop to block the enzyme will have side effects. So, a better approach is to quit smoking. Mochael Lerman, M.D., Ph.D.
By Kerry Grens
Engineered immunogens based on conserved patches of the virus’s envelope protein point to new strategies for vaccine design.
By Bob Grant
The predatory toxins employed by animals separated by millions of years of evolution are virtually identical, a study shows.
By Ruth Williams
A new high-throughput, transcriptome-wide assay determines RNA structures in vivo.
Kepler-452b revolves around a sun much like our own.
Multiple consecutive adenosine nucleotides can cause protein translation machinery to stall on messenger RNAs.
Researchers discover an unprecedented paleontological relic that may just rewrite the book on snake evolution.
Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.
View the August 2015 contents.
© 1986-2015 The Scientist